93
Views
44
CrossRef citations to date
0
Altmetric
Original Article

CTLA4Ig Prevents Initiation but not Evolution of Anti-phospholipid Syndrome in NZW/BXSB Mice

, , , , , , & show all
Pages 445-451 | Received 28 Jul 2004, Accepted 30 Jul 2004, Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ahlam Al Marzooqi, Alessia Leone, Jamal Al Saleh & Munther Khamashta. (2016) Current status and future prospects for the treatment of antiphospholipid syndrome. Expert Review of Clinical Immunology 12:9, pages 927-935.
Read now

Articles from other publishers (42)

Naomi I Maria, Julien Papoin, Chirag Raparia, Zeguo Sun, Rachel Josselsohn, Ailing Lu, Hani Katerji, Mahrukh M Syeda, David Polsky, Robert Paulson, Theodosia Kalfa, Betsy J Barnes, Weijia Zhang, Lionel Blanc & Anne Davidson. (2023) Human TLR8 induces inflammatory bone marrow erythromyeloblastic islands and anemia in SLE-prone mice. Life Science Alliance 6:10, pages e202302241.
Crossref
Anne Hubben & Keith R McCrae. (2022) Emerging Therapies in Antiphospholipid Syndrome. Transfusion Medicine Reviews 36:4, pages 195-203.
Crossref
Elliot H. Akama‐Garren & Michael C. Carroll. (2022) T cell help in the autoreactive germinal center. Scandinavian Journal of Immunology 95:6.
Crossref
Tam D. Quach, Weiqing Huang, Ranjit Sahu, Catherine M.M. Diadhiou, Chirag Raparia, Roshawn Johnson, Tung Ming Leung, Susan Malkiel, Peta Gay Ricketts, Stefania Gallucci, Çagla Tükel, Chaim O. Jacob, Martin L. Lesser, Yong-Rui Zou & Anne Davidson. (2022) Context-dependent induction of autoimmunity by TNF signaling deficiency. JCI Insight 7:5.
Crossref
Doruk Erkan. (2021) Expert Perspective: Management of Microvascular and Catastrophic Antiphospholipid Syndrome. Arthritis & Rheumatology 73:10, pages 1780-1790.
Crossref
Wei Li, Ahmed S. Elshikha, Caleb Cornaby, Xiangyu Teng, Georges Abboud, Josephine Brown, Xueyang Zou, Leilani Zeumer-Spataro, Brian Robusto, Seung-Chul Choi, Kristianna Fredenburg, Amy Major & Laurence Morel. (2020) T cells expressing the lupus susceptibility allele Pbx1d enhance autoimmunity and atherosclerosis in dyslipidemic mice. JCI Insight 5:11.
Crossref
Chrisanna Dobrowolski & Doruk Erkan. (2019) Treatment of antiphospholipid syndrome beyond anticoagulation. Clinical Immunology 206, pages 53-62.
Crossref
Maria G. Tektonidou. (2018) Antiphospholipid Syndrome Nephropathy: From Pathogenesis to Treatment. Frontiers in Immunology 9.
Crossref
S. Manfredo Vieira, M. Hiltensperger, V. KumarD. Zegarra-Ruiz, C. Dehner, N. Khan, F. R. C. Costa, E. Tiniakou, T. Greiling, W. Ruff, A. Barbieri, C. KriegelS. S. Mehta, J. R. Knight, D. Jain, A. L. Goodman & M. A. Kriegel. (2018) Translocation of a gut pathobiont drives autoimmunity in mice and humans. Science 359:6380, pages 1156-1161.
Crossref
Laurent Simonin, Elisabeth Pasquier, Christophe Leroyer, Divi Cornec, Julie Lemerle, Boutahar Bendaoud, Sophie Hillion, Jacques-Olivier Pers, Francis Couturaud & Yves Renaudineau. (2016) Lymphocyte Disturbances in Primary Antiphospholipid Syndrome and Application to Venous Thromboembolism Follow-Up. Clinical Reviews in Allergy & Immunology 53:1, pages 14-27.
Crossref
Ozan UnluDoruk Erkan. (2017) Catastrophic Antiphospholipid Syndrome: Candidate Therapies for a Potentially Lethal Disease. Annual Review of Medicine 68:1, pages 287-296.
Crossref
A. Kolyada, Q. Ke, I. Karageorgos, P. Mahlawat, D.A. Barrios, P.M. Kang & N. Beglova. (2016) Soluble analog of ApoER2 targeting beta2‐glycoprotein I in immune complexes counteracts hypertension in lupus‐prone mice with spontaneous antiphospholipid syndrome. Journal of Thrombosis and Haemostasis 14:6, pages 1298-1307.
Crossref
Alexis Boneparth, Megan Woods, Weiqing Huang, Meredith Akerman, Martin Lesser & Anne Davidson. (2016) The Effect of BAFF Inhibition on Autoreactive B-Cell Selection in Murine Systemic Lupus Erythematosus. Molecular Medicine 22:1, pages 173-182.
Crossref
Anne Davidson, Ramalingam Bethunaickan, Celine Berthier, Ranjit Sahu, Weijia Zhang & Matthias Kretzler. (2015) Molecular studies of lupus nephritis kidneys. Immunologic Research 63:1-3, pages 187-196.
Crossref
Alexis Boneparth, Weiqing Huang, Ramalingam Bethunaickan, Megan Woods, Ranjit Sahu, Shitij Arora, Meredith Akerman, Martin Lesser & Anne Davidson. (2015) TLR7 Influences Germinal Center Selection in Murine SLE. PLOS ONE 10:3, pages e0119925.
Crossref
Amaia Ugarte & Guillermo Ruiz Irastorza. (2015) Rituximab en el síndrome antifosfolípido: ¿siempre, nunca o a veces?. Medicina Clínica 144:3, pages 115-117.
Crossref
Isaac Pons, Gerard Espinosa & Ricard Cervera. (2015) Eficacia y seguridad de rituximab en el tratamiento del síndrome antifosfolipídico primario: análisis de 24 casos a partir de la revisión de la bibliografía. Medicina Clínica 144:3, pages 97-104.
Crossref
Isaac Pons, Gerard Espinosa & Ricard Cervera. (2015) Efficacy and safety of rituximab in the treatment of primary antiphospholipid syndrome: Analysis of 24 cases from the bibliography review. Medicina Clínica (English Edition) 144:3, pages 97-104.
Crossref
Amaia Ugarte & Guillermo Ruiz Irastorza. (2015) Rituximab in antiphospholipid syndrome: Always, never, sometimes?. Medicina Clínica (English Edition) 144:3, pages 115-117.
Crossref
Cecilia Beatrice Chighizola, Tania Ubiali & Pier Luigi Meroni. (2015) Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management—An Insight into Future Approaches. Journal of Immunology Research 2015, pages 1-20.
Crossref
Cecilia Beatrice Chighizola & Tania Ubiali. 2015. Antiphospholipid Antibody Syndrome. Antiphospholipid Antibody Syndrome 219 232 .
Shruti Chaturvedi & Keith R. McCrae. (2014) Recent advances in the antiphospholipid antibody syndrome. Current Opinion in Hematology 21:5, pages 371-379.
Crossref
Doruk Erkan, Cassyanne L. Aguiar, Danieli Andrade, Hannah Cohen, Maria J. Cuadrado, Adriana Danowski, Roger A. Levy, Thomas L. Ortel, Anisur Rahman, Jane E. Salmon, Maria G. Tektonidou, Rohan Willis & Michael D. Lockshin. (2014) 14th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends. Autoimmunity Reviews 13:6, pages 685-696.
Crossref
Alexey Kolyada, Andrew Porter & Natalia Beglova. (2014) Inhibition of thrombotic properties of persistent autoimmune anti-β2GPI antibodies in the mouse model of antiphospholipid syndrome. Blood 123:7, pages 1090-1097.
Crossref
Cloé Comarmond & Patrice Cacoub. (2013) Antiphospholipid syndrome: From pathogenesis to novel immunomodulatory therapies. Autoimmunity Reviews 12:7, pages 752-757.
Crossref
Doruk Erkan, JoAnn Vega, Glendalee Ramón, Elizabeth Kozora & Michael D. Lockshin. (2013) A pilot open‐label phase II trial of rituximab for non‐criteria manifestations of antiphospholipid syndrome. Arthritis & Rheumatism 65:2, pages 464-471.
Crossref
Saakshi Khattri, Gisele Zandman-Goddard & Elena Peeva. (2012) B-cell directed therapies in antiphospholipid antibody syndrome — New directions based on murine and human data. Autoimmunity Reviews 11:10, pages 717-722.
Crossref
Mariana Postal, Lilian TL Costallat & Simone Appenzeller. (2012) Biological Therapy in Systemic Lupus Erythematosus. International Journal of Rheumatology 2012, pages 1-9.
Crossref
Ramalingam Bethunaickan, Ranjit Sahu & Anne Davidson. 2012. Autoimmunity. Autoimmunity 207 232 .
Doruk Erkan, Anisur Rahman, Hannah Cohen, Samuel J. Machin & Silvia S. Pierangeli. 2012. Antiphospholipid Syndrome. Antiphospholipid Syndrome 261 287 .
Andrew M. Platt, Vivienne B. Gibson, Agapitos Patakas, Robert A. Benson, Steven G. Nadler, James M. Brewer, Iain B. McInnes & Paul Garside. (2010) Abatacept Limits Breach of Self-Tolerance in a Murine Model of Arthritis via Effects on the Generation of T Follicular Helper Cells. The Journal of Immunology 185:3, pages 1558-1567.
Crossref
Daniel Elbirt, Dalia Sthoeger, Ilan Asher & Zev Moshe Sthoeger. (2010) The management of systemic lupus erythematosus: Facts and controversies. Clinics in Dermatology 28:3, pages 330-336.
Crossref
SS PierangeliD. Erkan. (2010) Antiphospholipid syndrome treatment beyond anticoagulation: are we there yet?. Lupus 19:4, pages 475-485.
Crossref
D. ErkanMD Lockshin. (2010) Non-criteria manifestations of antiphospholipid syndrome. Lupus 19:4, pages 424-427.
Crossref
Meera Ramanujam, Philip Kahn, Weiqing Huang, Haiou Tao, Michael P. Madaio, Stephen M. Factor & Anne Davidson. (2009) Interferon-α treatment of female (NZW × BXSB)F 1 mice mimics some but not all features associated with the Yaa mutation . Arthritis & Rheumatism 60:4, pages 1096-1101.
Crossref
Doruk Erkan & Michael D Lockshin. (2009) New approaches for managing antiphospholipid syndrome. Nature Reviews Rheumatology 5:3, pages 160-170.
Crossref
Jessica Gordon, Diana Goldenberg, Doruk Erkan & Michael D. Lockshin. 2009. Antiphospholipid Syndrome in Systemic Autoimmune Diseases. Antiphospholipid Syndrome in Systemic Autoimmune Diseases 215 234 .
Philip Kahn, Meera Ramanujam, Ramalingam Bethunaickan, Weiqing Huang, Haiou Tao, Michael P. Madaio, Stephen M. Factor & Anne Davidson. (2008) Prevention of murine antiphospholipid syndrome by BAFF blockade. Arthritis & Rheumatism 58:9, pages 2824-2834.
Crossref
Kenneth J. Scalapino & David I. Daikh. (2008) CTLA‐4: a key regulatory point in the control of autoimmune disease. Immunological Reviews 223:1, pages 143-155.
Crossref
Meera Ramanujam & Anne Davidson. (2008) BAFF blockade for systemic lupus erythematosus: will the promise be fulfilled?. Immunological Reviews 223:1, pages 156-174.
Crossref
Meera Ramanujam & Anne Davidson. (2008) Targeting of the immune system in systemic lupus erythematosus. Expert Reviews in Molecular Medicine 10.
Crossref
A DavidsonB Diamond, D Wofsy & D Daikh. (2016) Block and tackle: CTLA4Ig takes on lupus. Lupus 14:3, pages 197-203.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.